Pulmonx Corporation Company Profile
NASDAQ: LUNGHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pulmonx at a glance
Pulmonx Corporation (NASDAQ: LUNG) is a Medical Devices company in the Healthcare sector headquartered in Redwood City, CA. Pulmonx is led by Mr. Glendon E. French and employs about 296 people. The company's shares have traded publicly since 2020.
At a market capitalization of $79.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001127537, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Pulmonx do?
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Business description based on the company's public filings.
Company information
- Legal name
- Pulmonx Corporation
- Ticker
- NASDAQ: LUNG
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Glendon E. French
- Employees
- 296
- Headquarters
- 700 Chesapeake Drive, Redwood City, CA, United States
- Phone
- 650 364 0400
- Website
- pulmonx.com
- IPO year
- 2020
- Market cap
- $79.02M
- SEC CIK
- 0001127537
Companies similar to Pulmonx
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LNSRLENSAR Inc. | 6.45 | -0.92% | $79.24M | vs LUNG |
| SERASera Prognostics Inc. Class A | 2.02 | -2.42% | $79.69M | vs LUNG |
| OMOutset Medical Inc. | 4.09 | -2.85% | $76.88M | vs LUNG |
| ECORelectroCore Inc. | 9.51 | -2.16% | $85.74M | vs LUNG |
| MBOTMicrobot Medical Inc. | 1.07 | -4.46% | $71.87M | vs LUNG |
| APYXApyx Medical Corporation | 2.36 | -7.45% | $99.41M | vs LUNG |
| HYPRHyperfine Inc. Class A | 0.9401 | +10.73% | $99.70M | vs LUNG |
| MYOMyomo Inc. | 1.41 | -2.76% | $55.85M | vs LUNG |